{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20250607",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "82501",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/021164Orig1s001ltr.pdf",
              "date": "20250609",
              "type": "Letter"
            },
            {
              "id": "82531",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021164Orig1s001lbl.pdf",
              "date": "20250610",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230922",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "75552",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/021164Orig1s000ltr.pdf",
              "date": "20230925",
              "type": "Letter"
            },
            {
              "id": "75557",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021164s000lbl.pdf",
              "date": "20230925",
              "type": "Label"
            },
            {
              "id": "76672",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/021164Orig1s000TOC.html",
              "date": "20231128",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA021164",
      "sponsor_name": "FABRE KRAMER",
      "openfda": {
        "application_number": [
          "NDA021164"
        ],
        "brand_name": [
          "EXXUA"
        ],
        "generic_name": [
          "GEPIRONE"
        ],
        "manufacturer_name": [
          "Aytu Therapeutics, LLC"
        ],
        "product_ndc": [
          "23594-150",
          "23594-151",
          "23594-152",
          "23594-153"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "GEPIRONE HYDROCHLORIDE"
        ],
        "rxcui": [
          "2672372",
          "2672379",
          "2672382",
          "2672385",
          "2672388",
          "2672391",
          "2672394",
          "2672397",
          "2732202",
          "2732203"
        ],
        "spl_id": [
          "414d62f1-85aa-cfa6-e063-6394a90a69fc"
        ],
        "spl_set_id": [
          "0c78edd8-6acb-433c-9d34-2527da8d64e1"
        ],
        "package_ndc": [
          "23594-150-30",
          "23594-150-32",
          "23594-151-30",
          "23594-152-30",
          "23594-153-30"
        ],
        "unii": [
          "80C9L8EP6V"
        ]
      },
      "products": [
        {
          "product_number": "003",
          "reference_drug": "Yes",
          "brand_name": "EXXUA",
          "active_ingredients": [
            {
              "name": "GEPIRONE HYDROCHLORIDE",
              "strength": "EQ 54.5MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "EXXUA",
          "active_ingredients": [
            {
              "name": "GEPIRONE HYDROCHLORIDE",
              "strength": "EQ 18.2MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "004",
          "reference_drug": "Yes",
          "brand_name": "EXXUA",
          "active_ingredients": [
            {
              "name": "GEPIRONE HYDROCHLORIDE",
              "strength": "EQ 72.6MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "EXXUA",
          "active_ingredients": [
            {
              "name": "GEPIRONE HYDROCHLORIDE",
              "strength": "EQ 36.3MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}